Apogee Therapeutics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APGE and other ETFs, options, and stocks.About APGE
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications.
CEOMichael Henderson
CEOMichael Henderson
Employees196
Employees196
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2022
Founded2022
Employees196
Employees196
APGE Key Statistics
Market cap5.73B
Market cap5.73B
Price-Earnings ratio-19.09
Price-Earnings ratio-19.09
Dividend yield—
Dividend yield—
Average volume1.05M
Average volume1.05M
High today—
High today—
Low today—
Low today—
Open price$78.94
Open price$78.94
Volume0.00
Volume0.00
52 Week high$84.56
52 Week high$84.56
52 Week low$26.20
52 Week low$26.20
Stock Snapshot
As of today, Apogee Therapeutics, Inc.(APGE) shares are valued at $82.43. The company's market cap stands at 5.73B, with a P/E ratio of -19.09.
On 2026-01-15, Apogee Therapeutics, Inc.(APGE) shares started trading at $78.94, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.05M.
Over the past 52 weeks, Apogee Therapeutics, Inc.(APGE) stock has traded between a high of $84.56 and a low of $26.20.
Over the past 52 weeks, Apogee Therapeutics, Inc.(APGE) stock has traded between a high of $84.56 and a low of $26.20.
Analyst ratings
94%
of 16 ratingsBuy
93.8%
Hold
6.3%
Sell
0%
People also own
Based on the portfolios of people who own APGE. This list is generated using Robinhood data, and it’s not a recommendation.